Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Entrada Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +9 vs. Q2 2025
- Shares held
- 28.5M
- −1.11M (−3.7%) vs. Q2 2025
- Total value
- $164.8M
- −$34.0M (−17.1%) vs. Q2 2025
- New holders
- 25
- 50 more added
- Sold out
- 16
- 28 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 346,756 | $2.01M | 0.00% | +183,659+112.6% | Added |
| Price T Rowe Associates Inc | 360,526 | $2.09M | 0.00% | −2,206,952−86.0% | Reduced |
| Dimensional Fund Advisors LP | 394,279 | $2.29M | 0.00% | −29,706−7.0% | Reduced |
| State Street Corp | 498,615 | $2.89M | 0.00% | +2,753+0.6% | Added |
| TCG Crossover Management, LLC | 584,955 | $3.39M | 0.17% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 594,300 | $3.45M | 0.00% | +214,800+56.6% | Added |
| Geode Capital Management, LLC | 645,119 | $3.74M | 0.00% | +13,565+2.1% | Added |
| StepStone Group LP | 761,277 | $4.42M | 2.08% | 00.0% | Unchanged |
| Millennium Management LLC | 836,609 | $4.85M | 0.00% | +666,287+391.2% | Added |
| Wellington Management Group LLP | 954,419 | $5.54M | 0.00% | −106,297−10.0% | Reduced |
| Vanguard Group Inc | 1,604,225 | $9.30M | 0.00% | −6350.0% | Reduced |
| BlackRock, Inc. | 2,044,044 | $11.9M | 0.00% | +21,894+1.1% | Added |
| 5AM Venture Management, LLC | 4,256,379 | $24.7M | 9.04% | −52,000−1.2% | Reduced |
| MPM Asset Management LLC | 4,381,062 | $25.4M | 57.09% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,865,819 | $28.2M | 0.20% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 67,334 | – | – | +67,334 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −1,521,281−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −102,008−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −87,387−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −75,120−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −28,340−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −24,734−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −16,805−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −15,785−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −15,277−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,208−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −7,575−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −2,868−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,256−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −393−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |